{"gene":"PROP1","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1998,"finding":"PROP1 mutations (including frameshift and missense) result in a gene product with reduced DNA-binding and transcriptional activation ability, as demonstrated by in vitro functional assays comparing mutant versus wild-type PROP1 activity; PROP1 is required for Pit1 (POU1F1) expression and is epistatic to Pit1 in pituitary development.","method":"In vitro DNA-binding and transcriptional activation assays; genetic epistasis in mouse models (Ames dwarf epistatic to Snell/Jackson dwarfism)","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro functional assays with mutagenesis replicated across multiple PROP1 mutations in the same and subsequent studies","pmids":["9462743"],"is_preprint":false},{"year":2000,"finding":"The F88S missense mutation in the first helix of the PROP1 homeodomain abolishes DNA binding to a PRDQ9 Prop1 response element in gel shift assays and reduces transcriptional activation of a luciferase reporter to ~34% of wild-type, demonstrating that the hydrophobic core of helix 1 is required for DNA binding.","method":"Gel shift (EMSA) assay and luciferase reporter transcriptional activation assay in transiently transfected TSA-201 cells","journal":"The Journal of clinical endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro binding and transcriptional activation assays with site-directed mutagenesis in a single study","pmids":["10946881"],"is_preprint":false},{"year":2001,"finding":"Constitutive (transgenic) overexpression of PROP1 in pituitary thyrotropes and gonadotropes delays terminal differentiation of gonadotropes, causes transient hypogonadotropic hypogonadism, impairs thyrotrope function, and increases susceptibility to pituitary adenomas and Rathke's cleft cysts, demonstrating that timely silencing of PROP1 is required for normal pituitary cell differentiation.","method":"Transgenic mouse overexpression; histological and hormonal phenotyping","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean transgenic gain-of-function with defined cellular and hormonal phenotypes, replicated in follow-up studies","pmids":["11371507"],"is_preprint":false},{"year":2002,"finding":"In Prop1-deficient mice, anterior pituitary progenitors fail to differentiate and are retained in the perilumenal area of Rathke's pouch, failing to migrate to the anterior lobe; after birth these pituitaries show enhanced apoptosis and reduced proliferation because the anterior lobe is not seeded with progenitors. In contrast, Lhx4 mutants show increased cell death and temporal shift in Lhx3 activation. Double Lhx4/Prop1 mutants exhibit complete failure of all anterior pituitary cell types to differentiate, indicating overlapping but mechanistically distinct roles.","method":"Genetic epistasis (double mutants); longitudinal histological analysis; pulse-label cell migration assay; apoptosis and proliferation quantification in mouse embryos","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with double-mutant analysis and multiple orthogonal cellular readouts","pmids":["12183375"],"is_preprint":false},{"year":2004,"finding":"Longitudinal studies in Prop1-deficient dwarf mice show that mutant pituitary cells are retained in the perilumenal region and fail to migrate and differentiate; after birth the mutant pituitary exhibits enhanced apoptosis and reduced proliferation due to failure to seed the anterior lobe with progenitors, providing a cellular mechanism for the pituitary hypoplasia seen in human PROP1 patients.","method":"Longitudinal volumetric analysis; BrdU pulse labeling for cell migration; apoptosis assay; proliferation cell counting in Prop1-deficient and wild-type mice","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal in vivo methods (pulse labeling, apoptosis, proliferation) in longitudinal study","pmids":["15591534"],"is_preprint":false},{"year":2004,"finding":"Prop1 deficiency in mice results in near-complete absence of Notch2 expression in the developing pituitary, while other panhypopituitary mutants do not show this effect; transgenic overexpression of Prop1 is not sufficient to enhance Notch2 expression, indicating that Prop1 is necessary but not sufficient for Notch2 expression, and that Notch signaling is downstream of or parallel to Prop1 in controlling pituitary progenitor differentiation.","method":"In situ hybridization and immunostaining in Prop1 mutant and transgenic mice; analysis of Notch pathway gene expression by spatial/temporal profiling","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function and gain-of-function in vivo with specific pathway (Notch2) readout","pmids":["14732396"],"is_preprint":false},{"year":2004,"finding":"The R73C mutation of PROP1 reduces transactivation capacity to 11.5% of wild-type and abolishes binding to a high-affinity DNA sequence in vitro, confirming R73 as a functionally critical residue in the homeodomain.","method":"In vitro transactivation assay and DNA binding (EMSA/gel shift) in transfected cells","journal":"The Journal of clinical endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro DNA-binding and transcriptional activation assays with defined mutant","pmids":["15531542"],"is_preprint":false},{"year":2005,"finding":"PROP1 is required for normal gonadotrope terminal differentiation; transgenic overexpression of PROP1 in gonadotropes and thyrotropes causes delayed LH/FSH synthesis without affecting GnRH receptor expression or transcription factors GATA2, NR5A1, TBX19, NR0B1, or TGFβ pathway members, suggesting PROP1 influences gonadotrope development by a distinct mechanism; microarray identified candidate genes Klrg1 and Prss28.","method":"Transgenic mouse overexpression; microarray gene expression analysis; immunostaining and hormonal phenotyping","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic gain-of-function with defined phenotype and exclusion of known pathway members; candidate genes not validated beyond microarray","pmids":["16384867"],"is_preprint":false},{"year":2008,"finding":"In Prop1/Hes1 double mutants, cells prematurely differentiate into ACTH and alphaGSU-producing cells within Rathke's pouch; N-cadherin downregulation (required for cell movement out of Rathke's pouch) does not occur in Prop1 single mutants (where N-cadherin remains high), but does occur in double mutants, allowing cells to exit but without correct migrational cues; Slug (EMT marker) is absent in the Prop1 mutant dorsal anterior lobe, indicating Prop1 is required for EMT and cell migration during pituitary organogenesis.","method":"Genetic epistasis (Prop1/Hes1 double mutants); immunostaining for N-cadherin, Slug, and pituitary hormones; in situ hybridization","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — double mutant epistasis with multiple molecular markers and defined cellular phenotypes","pmids":["18996108"],"is_preprint":false},{"year":2009,"finding":"HESX1 and PROP1 form a heterodimer on an inverted TAAT motif; HESX1 binds as a monomer to TAATT but not TAAT, and in the presence of PROP1 it develops binding to an inverted TAAT motif via heterodimer formation, suggesting that as PROP1 appears in pituitary development it alters HESX1 from a repressive monomer to a heterodimeric complex with altered DNA-binding specificity.","method":"EMSA with random oligonucleotide selection; co-incubation of HESX1 and PROP1 proteins","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro EMSA demonstrating heterodimer formation, single study without functional validation of heterodimer in vivo","pmids":["19879326"],"is_preprint":false},{"year":2009,"finding":"PROP1 binds preferentially as a dimer to palindromic TAAT sequences separated by 3 nucleotides (inverted TAAT motifs); dimeric binding to inverted TAAT motifs drives transcriptional activation, whereas monomeric binding to a single TAAT or inverted ATTA motif does not; SELEX identified the 11-nucleotide consensus binding motif with a required T at position 5.","method":"SELEX (Systematic Evolution of Ligands by EXponential enrichment); EMSA; transient transfection reporter assay","journal":"Molecular and cellular endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Strong — three orthogonal methods (SELEX, EMSA, reporter assay) in a single rigorous study defining the binding mechanism","pmids":["19524124"],"is_preprint":false},{"year":2009,"finding":"PROP1 is expressed in SOX2-expressing stem/progenitor cells in the rat pituitary from embryonic through postnatal periods; at E13.5 PROP1 is expressed in all Rathke's pouch cells; subsequently PROP1-positive cells localize to the marginal cell layer (stem cell niche); PROP1 transiently co-localizes with PIT1 but not with hormones in the embryonic period, indicating a role in converting SOX2+ progenitors to PIT1-lineage committed cells.","method":"Immunohistochemistry on rat embryonic and postnatal pituitary sections; co-localization analysis with SOX2, PIT1, and hormone markers","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization by immunohistochemistry across developmental time points, single lab, no functional manipulation","pmids":["19442651"],"is_preprint":false},{"year":2009,"finding":"GPS (GFRa2/Prop1/Stem) cells in the adult pituitary niche express PROP1 along with stem cell markers (Sox2, Sox9, Oct4) and form non-endocrine spheroids in culture that can differentiate into hormone-producing cells or neurons, indicating PROP1 marks a pituitary stem cell population with neuroectoderm potential.","method":"Immunostaining; in vitro spheroid formation and differentiation assay; BrdU label retention; telomere length analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization combined with in vitro functional differentiation assay, single lab","pmids":["19283075"],"is_preprint":false},{"year":2010,"finding":"TLE1 and TLE3 (Groucho-related corepressors) interact with PROP1 and repress PROP1 transcriptional activity independently of HESX1 via direct protein-protein interaction; HESX1 represses PROP1 and this repression is augmented by TLE1 and TLE3; constitutive expression of HESX1 alone (but not TLE3 alone) suppresses terminal differentiation of thyrotropes and gonadotropes in transgenic mice.","method":"Cell culture transcriptional repression assay; transgenic mouse model with constitutive HESX1 and/or TLE3 expression; protein-protein interaction assay","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell culture functional assays with transgenic in vivo validation, reciprocal interactions tested","pmids":["20181723"],"is_preprint":false},{"year":2016,"finding":"Genome-wide analysis of PROP1 DNA binding and gene expression effects in mutant mice, isolated stem cells, and engineered mouse cell lines revealed that PROP1 stimulates pituitary stem cells to undergo an epithelial-to-mesenchymal transition (EMT)-like process required for cell migration and differentiation; PROP1 binds to epithelial genes (e.g., Claudin 23) and EMT inducer genes (Zeb2, Notch2, Gli2); Zeb2 activation appears to be a key downstream step.","method":"ChIP-seq (genome-wide PROP1 DNA binding); RNA-seq in Prop1 mutant mice; functional assays in isolated pituitary stem cells and engineered mouse cell lines","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — genome-wide ChIP-seq plus transcriptomic analysis in multiple model systems defining a comprehensive PROP1-dependent gene regulatory network","pmids":["27351100"],"is_preprint":false},{"year":2016,"finding":"Lineage tracing with a Prop1-Cre mouse line demonstrated that all hormone-secreting cell types of both the anterior and intermediate pituitary lobes are descended from Prop1-expressing progenitors, establishing PROP1 as marking a common multipotent progenitor for all pituitary cell lineages including gonadotropes, corticotropes, and melanotropes (not just the PIT1 lineage).","method":"Transgenic Prop1-Cre lineage tracing in mice; Cre-dependent reporter expression","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic lineage tracing experiment with defined Cre driver; human PROP1 shown to functionally substitute for mouse Prop1 in rescue experiment","pmids":["26812162"],"is_preprint":false},{"year":2005,"finding":"A novel PROP1 mutation (W194X) truncating the protein in its transactivation domain reduces transactivation capacity to 34.4% of wild-type; unexpectedly, DNA-binding properties are also altered, indicating that the C-terminal end of PROP1 contributes to protein-DNA interaction.","method":"Transfection-based transactivation assay; DNA binding assay","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro functional assays (transactivation and DNA binding) with a single defined mutation, single study","pmids":["15941866"],"is_preprint":false},{"year":2020,"finding":"PROP1-dependent retinoic acid (RA) signaling regulates pituitary development: Prop1-mutant mice show reduced Aldh1a2 (the enzyme converting retinaldehyde to RA) expression; conditional deletion of Aldh1a2 or dominant-negative inhibition of RA signaling during pituitary organogenesis partially phenocopies Prop1-mutant mice, including embryonic pituitary dysmorphology and reduced hormone (especially thyrotropin) expression.","method":"Conditional mouse knockout (Aldh1a2); dominant-negative transgenic mouse model; gene expression analysis","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent genetic models (conditional KO and dominant-negative) each partially phenocopy Prop1 mutation, establishing RA signaling downstream of PROP1","pmids":["31913463"],"is_preprint":false},{"year":2018,"finding":"Retinoic acid (RA) signaling through RARα increases Prop1 mRNA expression in Rathke's pouch; ex vivo organ culture and in vitro reporter assays identified a cis-regulatory RARα-responsive element in the 5'-upstream region of the Prop1 gene, establishing RA/RARα as an upstream regulator of Prop1 transcription.","method":"Ex vivo Rathke's pouch organ culture with RA treatment; in vitro luciferase reporter assay with serial truncations of Prop1 5' upstream region; in situ hybridization","journal":"Journal of neuroendocrinology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — reporter assay with serial deletion constructs and ex vivo organ culture, single lab","pmids":["29356182"],"is_preprint":false},{"year":2007,"finding":"Comparative genomics and transgenic functional analysis identified three conserved regulatory elements of Prop1: a promoter-proximal element, an intronic element (first intron), and a downstream element; the intronic element is sufficient to confer dorsal expansion of pituitary expression in transgenic mice, and a BAC transgene containing Prop1 completely rescues the Prop1 mutant phenotype.","method":"Comparative genomics; BAC transgene rescue; enhancer assay in cell culture; transgenic mice with intronic element driving reporter","journal":"Mammalian genome","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic rescue and cell-culture enhancer assays, multiple genomic elements tested, single lab","pmids":["17557180"],"is_preprint":false},{"year":2015,"finding":"Reporter assays showed that SOX2 has cell type-dependent inhibitory and activating functions on Prop1 expression through the proximal and distal upstream regions respectively; RBP-J (Notch mediator) has small regulatory activity; 8 transcription factors (MSX2, PAX6, PIT1, PITX1, PITX2, RPF1, SOX8, SOX11) regulate Prop1 expression from its 3kb upstream region; 10 additional factors (including HES1, HEY1, FOXJ1) show synergy with SOX2.","method":"Luciferase reporter assay with 3kb upstream region and 1st intron of Prop1 in CHO and pituitary-related cell lines; systematic screening of 39 transcription factors","journal":"The Journal of reproduction and development","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — systematic reporter assay with defined genomic elements and multiple transcription factors, single lab, in vitro only","pmids":["26640231"],"is_preprint":false},{"year":2013,"finding":"NESTIN-expressing rapidly dividing progenitor cells in the pituitary transition from PROP1-positive to PIT1-positive during neonatal development, indicating that the cell supply system shifts from PROP1+ stem/progenitor cells to committed PIT1+ progenitors postnatally.","method":"Immunohistochemistry for NESTIN, PROP1, and PIT1 co-expression across developmental stages; BrdU incorporation analysis","journal":"Journal of neuroendocrinology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct multi-marker co-localization across developmental time points, consistent with lineage tracing data, single lab","pmids":["23855824"],"is_preprint":false},{"year":2014,"finding":"miR-593 and miR-511 directly target the 3'-UTR of the PROP1 gene and attenuate PROP1 protein expression, as validated by western blot and 3'-UTR reporter assay in HEK293T cells.","method":"3'-UTR luciferase reporter assay; western blot after miRNA transfection in HEK293T cells","journal":"International journal of molecular medicine","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct 3'-UTR reporter and western blot validation of miRNA targeting, single study","pmids":["25434367"],"is_preprint":false},{"year":2011,"finding":"In zebrafish, morpholino-mediated knockdown of prop1 reduces expression of pit1, prolactin (prl), and growth hormone (gh), and also unexpectedly downregulates lim3 (a gene not previously known to be Prop1-dependent); pituitary morphology and cellular organization are abnormal, but the effects are gradually reversed during late development despite persistent splice-blocking, suggesting additional compensatory pathways.","method":"Morpholino splice-blocking in zebrafish; in situ hybridization for pit1, prl, gh, tshβ, pitx3, lim3","journal":"General and comparative endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean morpholino knockdown in an orthologous model with multiple gene expression readouts, single lab","pmids":["21362424"],"is_preprint":false}],"current_model":"PROP1 is a pituitary-specific paired-like homeodomain transcription factor that functions as an obligatory dimer binding palindromic TAAT motifs to activate transcription; it acts upstream of POU1F1 (Pit1) and is required for pituitary stem/progenitor cells to undergo an EMT-like transition enabling their migration from Rathke's pouch to the anterior lobe, where they differentiate into all anterior and intermediate lobe hormone-producing cell types — a process also dependent on downstream Notch2 and retinoic acid signaling — while its timely silencing by HESX1/TLE corepressor complexes is equally essential for terminal differentiation."},"narrative":{"mechanistic_narrative":"PROP1 is a pituitary-specific paired-like homeodomain transcription factor that governs the migration and differentiation of multipotent anterior-pituitary progenitors, marking a common progenitor that gives rise to all hormone-secreting cell types of both anterior and intermediate lobes [PMID:27351100, PMID:26812162]. It functions through sequence-specific DNA binding: PROP1 binds preferentially as a dimer to palindromic (inverted) TAAT motifs separated by three nucleotides, and only this dimeric engagement drives transcriptional activation, whereas monomeric binding does not [PMID:19524124]. Mutations across the homeodomain (e.g. F88S, R73C) abolish or sharply reduce DNA binding and transactivation, and even C-terminal truncation (W194X) impairs both transactivation and DNA contact, defining the homeodomain and C-terminus as essential for function [PMID:10946881, PMID:15531542, PMID:15941866]. Genetically, PROP1 is required for and epistatic to Pit1 (POU1F1) expression [PMID:9462743], and in its absence progenitors are retained in the perilumenal region of Rathke's pouch, fail to migrate to the anterior lobe, and the gland later shows excess apoptosis and reduced proliferation [PMID:12183375, PMID:15591534]. Mechanistically PROP1 drives an EMT-like program required for this migration—it is needed for N-cadherin downregulation and Slug expression, and genome-wide it binds epithelial and EMT-inducer genes including Zeb2, Notch2, and Gli2, with Zeb2 activation a key downstream step [PMID:18996108, PMID:27351100]; Notch2 expression and retinoic-acid signaling (via Aldh1a2) act downstream, while RA/RARα also feeds back to activate Prop1 transcription [PMID:14732396, PMID:31913463, PMID:29356182]. Timely silencing of PROP1 is equally essential: HESX1 and Groucho-related corepressors TLE1/TLE3 directly bind and repress PROP1, and sustained PROP1 expression delays terminal differentiation of gonadotropes and thyrotropes [PMID:11371507, PMID:20181723]. Recessive PROP1 loss-of-function mutations cause combined pituitary hormone deficiency in humans, with the cellular basis being failure to seed the anterior lobe with progenitors [PMID:9462743, PMID:15591534].","teleology":[{"year":1998,"claim":"Established PROP1 as a DNA-binding transcriptional activator acting genetically upstream of Pit1, explaining a distinct dwarfism syndrome.","evidence":"In vitro DNA-binding/transactivation assays of mutant vs wild-type plus genetic epistasis in dwarf mice","pmids":["9462743"],"confidence":"High","gaps":["Did not define the DNA recognition motif","Direct downstream target genes not identified"]},{"year":2000,"claim":"Mapped a structural requirement for DNA binding by showing helix 1 of the homeodomain is essential, linking patient mutations to molecular loss-of-function.","evidence":"EMSA and luciferase reporter assays with the F88S mutant in TSA-201 cells","pmids":["10946881"],"confidence":"High","gaps":["Single mutation; full homeodomain structure-function not mapped"]},{"year":2001,"claim":"Showed that PROP1 must be silenced on schedule, since constitutive overexpression delays differentiation and promotes pituitary lesions.","evidence":"Transgenic mouse gain-of-function with histological and hormonal phenotyping","pmids":["11371507"],"confidence":"High","gaps":["Mechanism of differentiation delay not resolved","Repressors mediating silencing not yet identified"]},{"year":2002,"claim":"Provided the cellular basis for hypopituitarism by showing Prop1-null progenitors are trapped in Rathke's pouch and fail to migrate, distinct from Lhx4 function.","evidence":"Double-mutant epistasis, pulse-label migration, apoptosis/proliferation assays in mouse embryos","pmids":["12183375"],"confidence":"High","gaps":["Molecular driver of migration failure not yet defined"]},{"year":2004,"claim":"Identified Notch2 as a PROP1-dependent pathway component, placing Notch signaling downstream of or parallel to PROP1 in progenitor control.","evidence":"In situ hybridization/immunostaining in Prop1 loss- and gain-of-function mice","pmids":["14732396"],"confidence":"High","gaps":["PROP1 not sufficient for Notch2, so co-factors unknown","Direct vs indirect regulation unresolved at this stage"]},{"year":2004,"claim":"Quantified the postnatal consequences of failed progenitor seeding (apoptosis, reduced proliferation), mechanistically connecting mouse data to human pituitary hypoplasia.","evidence":"Longitudinal volumetric, BrdU migration, apoptosis and proliferation analyses","pmids":["15591534"],"confidence":"High","gaps":["Transcriptional targets driving the phenotype not identified"]},{"year":2005,"claim":"Refined the structure-function map by showing the C-terminal transactivation domain also contributes to DNA binding.","evidence":"Transfection transactivation and DNA-binding assays of the W194X truncation","pmids":["15941866"],"confidence":"Medium","gaps":["Single mutation, single study","Structural basis of C-terminal DNA contribution unknown"]},{"year":2005,"claim":"Showed PROP1 controls gonadotrope timing through a mechanism independent of known gonadotrope transcription factors, nominating new candidate targets.","evidence":"Transgenic overexpression with microarray and hormonal phenotyping","pmids":["16384867"],"confidence":"Medium","gaps":["Candidate genes Klrg1/Prss28 not validated beyond microarray","Direct targets vs secondary effects unresolved"]},{"year":2007,"claim":"Defined cis-regulatory architecture of Prop1 and confirmed functional sufficiency via complete BAC rescue.","evidence":"Comparative genomics, BAC transgene rescue, enhancer assays, transgenic intronic-element reporter","pmids":["17557180"],"confidence":"Medium","gaps":["Trans-acting factors at each element not identified here","Single lab"]},{"year":2008,"claim":"Identified PROP1 as a driver of EMT and migration, showing it is required for N-cadherin downregulation and Slug expression for exit from Rathke's pouch.","evidence":"Prop1/Hes1 double-mutant epistasis with N-cadherin, Slug and hormone marker staining","pmids":["18996108"],"confidence":"High","gaps":["Direct EMT target genes not yet mapped genome-wide","Migrational guidance cues unresolved"]},{"year":2009,"claim":"Defined the precise DNA recognition mechanism: dimeric binding to inverted TAAT motifs spaced by 3 nt is required for activation.","evidence":"SELEX, EMSA, and reporter assays","pmids":["19524124"],"confidence":"High","gaps":["No co-crystal structure of the PROP1 dimer on DNA"]},{"year":2009,"claim":"Showed PROP1 can convert HESX1 from a repressive monomer into a heterodimer with altered DNA specificity, linking the two factors biochemically.","evidence":"EMSA with random oligonucleotide selection and HESX1/PROP1 co-incubation","pmids":["19879326"],"confidence":"Medium","gaps":["Heterodimer function not validated in vivo","Single in vitro study"]},{"year":2009,"claim":"Localized PROP1 to SOX2+ stem/progenitor cells and a stem-cell niche, supporting a role in converting progenitors to the PIT1 lineage.","evidence":"Immunohistochemistry and co-localization across rat developmental stages; in vitro spheroid differentiation of GPS cells","pmids":["19442651","19283075"],"confidence":"Medium","gaps":["No functional manipulation in these descriptive studies","Single-lab observations"]},{"year":2010,"claim":"Identified the corepressor machinery silencing PROP1, showing TLE1/TLE3 and HESX1 directly repress its activity and constitutive HESX1 blocks terminal differentiation.","evidence":"Cell-culture repression and interaction assays plus transgenic HESX1/TLE3 mice","pmids":["20181723"],"confidence":"High","gaps":["Endogenous timing of repressor recruitment not mapped","Genomic loci of repression unknown"]},{"year":2011,"claim":"Confirmed conserved PROP1 function in an orthologous vertebrate and revealed compensatory pathways during late development.","evidence":"Morpholino splice-blocking in zebrafish with in situ hybridization for pit1, prl, gh, lim3","pmids":["21362424"],"confidence":"Medium","gaps":["Nature of compensation unknown","Knockdown not genetic null"]},{"year":2013,"claim":"Documented the postnatal lineage shift from PROP1+ stem/progenitors to committed PIT1+ progenitors.","evidence":"Immunohistochemistry for NESTIN/PROP1/PIT1 and BrdU across developmental stages","pmids":["23855824"],"confidence":"Medium","gaps":["Descriptive co-localization without functional perturbation"]},{"year":2016,"claim":"Defined the genome-wide PROP1 regulatory network, mechanistically establishing EMT control via direct binding to epithelial and EMT-inducer genes with Zeb2 as a key step.","evidence":"ChIP-seq and RNA-seq in mutant mice, isolated stem cells, and engineered cell lines","pmids":["27351100"],"confidence":"High","gaps":["Direct vs indirect status of individual targets not all dissected","Co-factor occupancy not fully mapped"]},{"year":2016,"claim":"Lineage tracing established PROP1 as marking a common multipotent progenitor for all anterior and intermediate lobe lineages, not just the PIT1 lineage, and confirmed human PROP1 can substitute functionally.","evidence":"Prop1-Cre lineage tracing with Cre-dependent reporter and human PROP1 rescue","pmids":["26812162"],"confidence":"High","gaps":["Timing of fate restriction within the progenitor pool not resolved"]},{"year":2018,"claim":"Placed RA/RARα signaling upstream of Prop1 transcription via a defined cis-regulatory element.","evidence":"Ex vivo Rathke's pouch organ culture with RA and luciferase reporter truncation assays","pmids":["29356182"],"confidence":"Medium","gaps":["In vivo requirement of the RARα element not tested","Single lab"]},{"year":2020,"claim":"Showed RA signaling also acts downstream of PROP1, with Aldh1a2-dependent RA production required for normal pituitary morphogenesis and hormone expression.","evidence":"Conditional Aldh1a2 knockout and dominant-negative RA-signaling transgenic mice, partially phenocopying Prop1 mutants","pmids":["31913463"],"confidence":"High","gaps":["Direct PROP1 regulation of Aldh1a2 not demonstrated","Feed-forward vs feedback architecture of RA-Prop1 loop not fully resolved"]},{"year":null,"claim":"How PROP1 dimer occupancy is dynamically switched between activation (with target genes) and repression (with HESX1/TLE) at specific loci during the developmental window remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of PROP1 dimer on inverted TAAT DNA","Endogenous timing/loci of HESX1-TLE recruitment vs activation not mapped","Full set of direct EMT targets driving migration not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,6,10,14]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,6,10,16]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,10,14]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,8,14,15]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,10,14]}],"complexes":[],"partners":["HESX1","TLE1","TLE3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O75360","full_name":"Homeobox protein prophet of Pit-1","aliases":["Pituitary-specific homeodomain factor"],"length_aa":226,"mass_kda":25.0,"function":"Possibly involved in the ontogenesis of pituitary gonadotropes, as well as somatotropes, lactotropes and caudomedial thyrotropes","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O75360/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PROP1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PROP1","total_profiled":1310},"omim":[{"mim_id":"613986","title":"PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6","url":"https://www.omim.org/entry/613986"},{"mim_id":"613038","title":"PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 1; CPHD1","url":"https://www.omim.org/entry/613038"},{"mim_id":"602149","title":"PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 1; PITX1","url":"https://www.omim.org/entry/602149"},{"mim_id":"601802","title":"HESX HOMEOBOX 1; HESX1","url":"https://www.omim.org/entry/601802"},{"mim_id":"601538","title":"PROP PAIRED-LIKE HOMEOBOX 1; PROP1","url":"https://www.omim.org/entry/601538"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"pituitary gland","ntpm":1.1}],"url":"https://www.proteinatlas.org/search/PROP1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"O75360","domains":[{"cath_id":"1.10.10.60","chopping":"79-134","consensus_level":"high","plddt":95.9716,"start":79,"end":134}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75360","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75360-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75360-F1-predicted_aligned_error_v6.png","plddt_mean":69.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PROP1","jax_strain_url":"https://www.jax.org/strain/search?query=PROP1"},"sequence":{"accession":"O75360","fasta_url":"https://rest.uniprot.org/uniprotkb/O75360.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75360/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75360"}},"corpus_meta":[{"pmid":"9462743","id":"PMC_9462743","title":"Mutations in PROP1 cause familial combined pituitary hormone deficiency.","date":"1998","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9462743","citation_count":382,"is_preprint":false},{"pmid":"9745452","id":"PMC_9745452","title":"The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency.","date":"1998","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/9745452","citation_count":151,"is_preprint":false},{"pmid":"9768691","id":"PMC_9768691","title":"Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg-->Cys at codon 120 (R120C).","date":"1998","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/9768691","citation_count":143,"is_preprint":false},{"pmid":"15591534","id":"PMC_15591534","title":"Role of PROP1 in pituitary gland growth.","date":"2004","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15591534","citation_count":141,"is_preprint":false},{"pmid":"10323394","id":"PMC_10323394","title":"\"Hot spot\" in the PROP1 gene responsible for combined pituitary hormone deficiency.","date":"1999","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10323394","citation_count":141,"is_preprint":false},{"pmid":"19283075","id":"PMC_19283075","title":"A GRFa2/Prop1/stem (GPS) cell niche in the pituitary.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19283075","citation_count":137,"is_preprint":false},{"pmid":"12183375","id":"PMC_12183375","title":"Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12183375","citation_count":122,"is_preprint":false},{"pmid":"10084575","id":"PMC_10084575","title":"Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene.","date":"1999","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10084575","citation_count":118,"is_preprint":false},{"pmid":"12414875","id":"PMC_12414875","title":"Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or PROP-1 genes.","date":"2002","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12414875","citation_count":101,"is_preprint":false},{"pmid":"14732396","id":"PMC_14732396","title":"Developmental regulation of Notch signaling genes in the embryonic pituitary: Prop1 deficiency affects Notch2 expression.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/14732396","citation_count":97,"is_preprint":false},{"pmid":"9824293","id":"PMC_9824293","title":"Human Prop-1: cloning, mapping, genomic structure. Mutations in familial combined pituitary hormone deficiency.","date":"1998","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9824293","citation_count":96,"is_preprint":false},{"pmid":"11371507","id":"PMC_11371507","title":"Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11371507","citation_count":95,"is_preprint":false},{"pmid":"15472232","id":"PMC_15472232","title":"PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis.","date":"2004","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15472232","citation_count":93,"is_preprint":false},{"pmid":"9661653","id":"PMC_9661653","title":"Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency.","date":"1998","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/9661653","citation_count":92,"is_preprint":false},{"pmid":"11549703","id":"PMC_11549703","title":"PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency.","date":"2001","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11549703","citation_count":89,"is_preprint":false},{"pmid":"9920061","id":"PMC_9920061","title":"Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene.","date":"1999","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/9920061","citation_count":80,"is_preprint":false},{"pmid":"11134108","id":"PMC_11134108","title":"Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion.","date":"2000","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11134108","citation_count":78,"is_preprint":false},{"pmid":"19442651","id":"PMC_19442651","title":"PROP1 coexists with SOX2 and induces PIT1-commitment cells.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19442651","citation_count":75,"is_preprint":false},{"pmid":"11549674","id":"PMC_11549674","title":"Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation.","date":"2001","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11549674","citation_count":71,"is_preprint":false},{"pmid":"15963055","id":"PMC_15963055","title":"Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD).","date":"2005","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15963055","citation_count":70,"is_preprint":false},{"pmid":"27351100","id":"PMC_27351100","title":"PROP1 triggers epithelial-mesenchymal transition-like process in pituitary stem cells.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/27351100","citation_count":63,"is_preprint":false},{"pmid":"15670191","id":"PMC_15670191","title":"Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia.","date":"2005","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15670191","citation_count":63,"is_preprint":false},{"pmid":"15126542","id":"PMC_15126542","title":"Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe.","date":"2004","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15126542","citation_count":61,"is_preprint":false},{"pmid":"12153609","id":"PMC_12153609","title":"A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty.","date":"2002","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12153609","citation_count":53,"is_preprint":false},{"pmid":"26812162","id":"PMC_26812162","title":"All Hormone-Producing Cell Types of the Pituitary Intermediate and Anterior Lobes Derive From Prop1-Expressing Progenitors.","date":"2016","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26812162","citation_count":52,"is_preprint":false},{"pmid":"10946881","id":"PMC_10946881","title":"Combined pituitary hormone deficiency caused by a novel mutation of a highly conserved residue (F88S) in the homeodomain of PROP-1.","date":"2000","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10946881","citation_count":50,"is_preprint":false},{"pmid":"12464226","id":"PMC_12464226","title":"The spectrum of hypopituitarism caused by PROP1 mutations.","date":"2002","source":"Best practice & research. Clinical endocrinology & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12464226","citation_count":48,"is_preprint":false},{"pmid":"18996108","id":"PMC_18996108","title":"Premature differentiation and aberrant movement of pituitary cells lacking both Hes1 and Prop1.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18996108","citation_count":47,"is_preprint":false},{"pmid":"16131601","id":"PMC_16131601","title":"Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects.","date":"2005","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16131601","citation_count":46,"is_preprint":false},{"pmid":"10658742","id":"PMC_10658742","title":"MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations.","date":"2000","source":"AJR. American journal of roentgenology","url":"https://pubmed.ncbi.nlm.nih.gov/10658742","citation_count":46,"is_preprint":false},{"pmid":"10626543","id":"PMC_10626543","title":"Combined pituitary hormone deficiency: role of Pit-1 and Prop-1.","date":"1999","source":"Acta paediatrica (Oslo, Norway : 1992). Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/10626543","citation_count":43,"is_preprint":false},{"pmid":"15941866","id":"PMC_15941866","title":"An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain.","date":"2005","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15941866","citation_count":43,"is_preprint":false},{"pmid":"11081182","id":"PMC_11081182","title":"A mutational hot spot in the Prop-1 gene in Russian children with combined pituitary hormone deficiency.","date":"1998","source":"Pituitary","url":"https://pubmed.ncbi.nlm.nih.gov/11081182","citation_count":41,"is_preprint":false},{"pmid":"10946868","id":"PMC_10946868","title":"Molecular analysis of LHX3 and PROP-1 in pituitary hormone deficiency patients with posterior pituitary ectopia.","date":"2000","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10946868","citation_count":40,"is_preprint":false},{"pmid":"11022176","id":"PMC_11022176","title":"Central hypocortisolism as part of combined pituitary hormone deficiency due to mutations of PROP-1 gene.","date":"2000","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11022176","citation_count":38,"is_preprint":false},{"pmid":"16984240","id":"PMC_16984240","title":"PROP1 gene analysis in Portuguese patients with combined pituitary hormone deficiency.","date":"2006","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16984240","citation_count":34,"is_preprint":false},{"pmid":"14646405","id":"PMC_14646405","title":"Clinical characteristics and molecular analysis of PIT1, PROP1,LHX3, and HESX1 in combined pituitary hormone deficiency patients with abnormal pituitary MR imaging.","date":"2003","source":"Hormone research","url":"https://pubmed.ncbi.nlm.nih.gov/14646405","citation_count":34,"is_preprint":false},{"pmid":"34165428","id":"PMC_34165428","title":"The Prop1-like homeobox gene unc-42 specifies the identity of synaptically connected neurons.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34165428","citation_count":32,"is_preprint":false},{"pmid":"18157385","id":"PMC_18157385","title":"Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency.","date":"2007","source":"Arquivos brasileiros de endocrinologia e metabologia","url":"https://pubmed.ncbi.nlm.nih.gov/18157385","citation_count":32,"is_preprint":false},{"pmid":"20389107","id":"PMC_20389107","title":"PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency.","date":"2010","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/20389107","citation_count":32,"is_preprint":false},{"pmid":"19128366","id":"PMC_19128366","title":"Molecular analysis of novel PROP1 mutations associated with combined pituitary hormone deficiency (CPHD).","date":"2008","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19128366","citation_count":32,"is_preprint":false},{"pmid":"16384867","id":"PMC_16384867","title":"Role of prophet of Pit1 (PROP1) in gonadotrope differentiation and puberty.","date":"2005","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16384867","citation_count":31,"is_preprint":false},{"pmid":"23245960","id":"PMC_23245960","title":"Short communication: A missense mutation in the PROP1 (prophet of Pit 1) gene affects male fertility and milk production traits in the US Holstein population.","date":"2012","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/23245960","citation_count":30,"is_preprint":false},{"pmid":"15531542","id":"PMC_15531542","title":"A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies.","date":"2004","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15531542","citation_count":30,"is_preprint":false},{"pmid":"16918947","id":"PMC_16918947","title":"Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion.","date":"2006","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16918947","citation_count":27,"is_preprint":false},{"pmid":"24029076","id":"PMC_24029076","title":"A critical functional missense mutation (H173R) in the bovine PROP1 gene significantly affects growth traits in cattle.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/24029076","citation_count":27,"is_preprint":false},{"pmid":"24178788","id":"PMC_24178788","title":"High prevalence of PROP1 defects in Lithuania: phenotypic findings in an ethnically homogenous cohort of patients with multiple pituitary hormone deficiency.","date":"2013","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24178788","citation_count":26,"is_preprint":false},{"pmid":"20181723","id":"PMC_20181723","title":"Corepressors TLE1 and TLE3 interact with HESX1 and PROP1.","date":"2010","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20181723","citation_count":25,"is_preprint":false},{"pmid":"26059845","id":"PMC_26059845","title":"Genesis of two most prevalent PROP1 gene variants causing combined pituitary hormone deficiency in 21 populations.","date":"2015","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/26059845","citation_count":25,"is_preprint":false},{"pmid":"22086512","id":"PMC_22086512","title":"PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without β-catenin mutations.","date":"2011","source":"Clinics (Sao Paulo, Brazil)","url":"https://pubmed.ncbi.nlm.nih.gov/22086512","citation_count":23,"is_preprint":false},{"pmid":"31913463","id":"PMC_31913463","title":"PROP1-Dependent Retinoic Acid Signaling Regulates Developmental Pituitary Morphogenesis and Hormone Expression.","date":"2020","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31913463","citation_count":23,"is_preprint":false},{"pmid":"10329025","id":"PMC_10329025","title":"Combined pituitary hormone deficiency in an inbred Brazilian kindred associated with a mutation in the PROP-1 gene.","date":"1999","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10329025","citation_count":23,"is_preprint":false},{"pmid":"16544023","id":"PMC_16544023","title":"[Standardization of DNA extraction with NaCl from oral mucosa cells: application in PROP1 gene study].","date":"2006","source":"Arquivos brasileiros de endocrinologia e metabologia","url":"https://pubmed.ncbi.nlm.nih.gov/16544023","citation_count":22,"is_preprint":false},{"pmid":"15012608","id":"PMC_15012608","title":"Prolonged jaundice and hypothyroidism as the presenting symptoms in a neonate with a novel Prop1 gene mutation (Q83X).","date":"2004","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15012608","citation_count":22,"is_preprint":false},{"pmid":"25500790","id":"PMC_25500790","title":"Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study.","date":"2014","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/25500790","citation_count":22,"is_preprint":false},{"pmid":"23855824","id":"PMC_23855824","title":"Rapid transition of NESTIN-expressing dividing cells from PROP1-positive to PIT1-positive advances prenatal pituitary development.","date":"2013","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23855824","citation_count":21,"is_preprint":false},{"pmid":"17526936","id":"PMC_17526936","title":"High prevalence of PROP1 gene mutations in Hungarian patients with childhood-onset combined anterior pituitary hormone deficiency.","date":"2006","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/17526936","citation_count":20,"is_preprint":false},{"pmid":"27756091","id":"PMC_27756091","title":"Identification of Novel PROP1 and POU1F1 Mutations in Patients with Combined Pituitary Hormone Deficiency.","date":"2016","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/27756091","citation_count":18,"is_preprint":false},{"pmid":"22024773","id":"PMC_22024773","title":"Mutations and pituitary morphology in a series of 82 patients with PROP1 gene defects.","date":"2011","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/22024773","citation_count":18,"is_preprint":false},{"pmid":"11822586","id":"PMC_11822586","title":"Pseudotumor of the pituitary due to PROP-1 deletion.","date":"2002","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/11822586","citation_count":18,"is_preprint":false},{"pmid":"17557180","id":"PMC_17557180","title":"Comparative genomics reveals functional transcriptional control sequences in the Prop1 gene.","date":"2007","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/17557180","citation_count":17,"is_preprint":false},{"pmid":"21104025","id":"PMC_21104025","title":"Identification of SNPs within the sheep PROP1 gene and their effects on wool traits.","date":"2010","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21104025","citation_count":16,"is_preprint":false},{"pmid":"15521968","id":"PMC_15521968","title":"A novel PROP1 gene mutation (157delA) in Japanese siblings with combined anterior pituitary hormone deficiency.","date":"2004","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15521968","citation_count":16,"is_preprint":false},{"pmid":"18636109","id":"PMC_18636109","title":"Pituitary changes in Prop1 transgenic mice: hormone producing tumors and signet-ring type gonadotropes.","date":"2008","source":"Acta histochemica et cytochemica","url":"https://pubmed.ncbi.nlm.nih.gov/18636109","citation_count":16,"is_preprint":false},{"pmid":"14614227","id":"PMC_14614227","title":"PROP-1 gene mutation (R120C) causing combined pituitary hormone deficiencies with variable clinical course in eight siblings of one Jewish Moroccan family.","date":"2003","source":"Hormone research","url":"https://pubmed.ncbi.nlm.nih.gov/14614227","citation_count":16,"is_preprint":false},{"pmid":"12859410","id":"PMC_12859410","title":"Two new PROP1 gene mutations responsible for compound pituitary hormone deficiency.","date":"2003","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12859410","citation_count":16,"is_preprint":false},{"pmid":"12006708","id":"PMC_12006708","title":"Familial combined pituitary hormone deficiency caused by PROP-1 gene mutation. Growth patterns and MRI studies in untreated subjects.","date":"2002","source":"Hormone research","url":"https://pubmed.ncbi.nlm.nih.gov/12006708","citation_count":16,"is_preprint":false},{"pmid":"24026438","id":"PMC_24026438","title":"Three-dimensional studies of Prop1-expressing cells in the rat pituitary just before birth.","date":"2013","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/24026438","citation_count":15,"is_preprint":false},{"pmid":"16308835","id":"PMC_16308835","title":"Short-term caloric restriction does not modify the in vivo insulin signaling pathway leading to Akt activation in skeletal muscle of Ames dwarf (Prop1(df)/Prop1(df)) mice.","date":"2005","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/16308835","citation_count":14,"is_preprint":false},{"pmid":"29356182","id":"PMC_29356182","title":"Retinoic acid signalling is a candidate regulator of the expression of pituitary-specific transcription factor Prop1 in the developing rodent pituitary.","date":"2018","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29356182","citation_count":14,"is_preprint":false},{"pmid":"10902805","id":"PMC_10902805","title":"Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion.","date":"2000","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10902805","citation_count":14,"is_preprint":false},{"pmid":"26111865","id":"PMC_26111865","title":"Novel Mutations in HESX1 and PROP1 Genes in Combined Pituitary Hormone Deficiency.","date":"2015","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/26111865","citation_count":13,"is_preprint":false},{"pmid":"15302300","id":"PMC_15302300","title":"Ovulation induction and successful pregnancy outcome in two patients with Prop1 gene mutations.","date":"2004","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/15302300","citation_count":13,"is_preprint":false},{"pmid":"22143287","id":"PMC_22143287","title":"Genetic background of Prop1(df) mutants provides remarkable protection against hypothyroidism-induced hearing impairment.","date":"2011","source":"Journal of the Association for Research in Otolaryngology : JARO","url":"https://pubmed.ncbi.nlm.nih.gov/22143287","citation_count":13,"is_preprint":false},{"pmid":"22113335","id":"PMC_22113335","title":"Three-dimensional studies of Prop1-expressing cells in the rat pituitary primordium of Rathke's pouch.","date":"2011","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/22113335","citation_count":13,"is_preprint":false},{"pmid":"23692781","id":"PMC_23692781","title":"Frequency of mutations in PROP-1 gene in Turkish children with combined pituitary hormone deficiency.","date":"2012","source":"The Turkish journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/23692781","citation_count":13,"is_preprint":false},{"pmid":"21362424","id":"PMC_21362424","title":"Involvement of Prop1 homeobox gene in the early development of fish pituitary gland.","date":"2011","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21362424","citation_count":12,"is_preprint":false},{"pmid":"19031010","id":"PMC_19031010","title":"A novel missense (A79V) mutation of goat PROP1 gene and its association with production traits.","date":"2008","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/19031010","citation_count":12,"is_preprint":false},{"pmid":"18594277","id":"PMC_18594277","title":"Basic science and clinical research advances in the pituitary transcription factors: Pit-1 and Prop-1.","date":"2008","source":"Current opinion in endocrinology, diabetes, and obesity","url":"https://pubmed.ncbi.nlm.nih.gov/18594277","citation_count":12,"is_preprint":false},{"pmid":"28734020","id":"PMC_28734020","title":"Molecular analysis of brazilian patients with combined pituitary hormone deficiency and orthotopic posterior pituitary lobe reveals eight different PROP1 alterations with three novel mutations.","date":"2017","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28734020","citation_count":12,"is_preprint":false},{"pmid":"11592567","id":"PMC_11592567","title":"Insufficient adrenarche in patients with combined pituitary hormone deficiency caused by a PROP-1 gene defect.","date":"2001","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/11592567","citation_count":12,"is_preprint":false},{"pmid":"16394624","id":"PMC_16394624","title":"High level expression of Prop-1 gene in gonadotropic cell lines.","date":"2005","source":"The Journal of reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/16394624","citation_count":11,"is_preprint":false},{"pmid":"10773688","id":"PMC_10773688","title":"Cloning, characterization, and physical mapping of the canine Prop-1 gene (PROP1): exclusion as a candidate for combined pituitary hormone deficiency in German shepherd dogs.","date":"2000","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10773688","citation_count":11,"is_preprint":false},{"pmid":"12812307","id":"PMC_12812307","title":"Adrenocorticotrope deficiency with clinical evidence for late onset in combined pituitary hormone deficiency caused by a homozygous 301-302delAG mutation of the PROP1 gene.","date":"2002","source":"Pituitary","url":"https://pubmed.ncbi.nlm.nih.gov/12812307","citation_count":11,"is_preprint":false},{"pmid":"14530604","id":"PMC_14530604","title":"Long-term follow-up of childhood-onset hypopituitarism in patients with the PROP-1 gene mutation.","date":"2003","source":"Hormone research","url":"https://pubmed.ncbi.nlm.nih.gov/14530604","citation_count":10,"is_preprint":false},{"pmid":"30316920","id":"PMC_30316920","title":"Gene polymorphisms in PROP1 associated with growth traits in sheep.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/30316920","citation_count":9,"is_preprint":false},{"pmid":"25434367","id":"PMC_25434367","title":"Circulating microRNA profiles and the identification of miR-593 and miR-511 which directly target the PROP1 gene in children with combined pituitary hormone deficiency.","date":"2014","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25434367","citation_count":9,"is_preprint":false},{"pmid":"23831233","id":"PMC_23831233","title":"Suprasellar mass mimicking a hypothalamic glioma in a patient with a complete PROP1 deletion.","date":"2013","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23831233","citation_count":9,"is_preprint":false},{"pmid":"20395664","id":"PMC_20395664","title":"A large deletion of PROP1 gene in patients with combined pituitary hormone deficiency from two unrelated Chinese pedigrees.","date":"2010","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/20395664","citation_count":9,"is_preprint":false},{"pmid":"19774847","id":"PMC_19774847","title":"Pituitary enlargement in patients with PROP1 gene inactivating mutation represents cystic hyperplasia of the intermediate pituitary lobe. Histopathology and over 10 years follow-up of two patients.","date":"2009","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/19774847","citation_count":9,"is_preprint":false},{"pmid":"16794371","id":"PMC_16794371","title":"Pituitary size fluctuation in long-term MR studies of PROP1 deficient patients: A persistent pathophysiological mechanism?","date":"2006","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/16794371","citation_count":9,"is_preprint":false},{"pmid":"20022531","id":"PMC_20022531","title":"Ames dwarf (Prop1(df)/Prop1(df)) mice display increased sensitivity of the major GH-signaling pathways in liver and skeletal muscle.","date":"2009","source":"Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/20022531","citation_count":8,"is_preprint":false},{"pmid":"19879326","id":"PMC_19879326","title":"Pituitary homeodomain transcription factors HESX1 and PROP1 form a heterodimer on the inverted TAAT motif.","date":"2009","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19879326","citation_count":8,"is_preprint":false},{"pmid":"16759034","id":"PMC_16759034","title":"Congenital combined pituitary hormone deficiency attributable to a novel PROP1 mutation (467insT).","date":"2006","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/16759034","citation_count":8,"is_preprint":false},{"pmid":"26608600","id":"PMC_26608600","title":"Two coexisting heterozygous frameshift mutations in PROP1 are responsible for a different phenotype of combined pituitary hormone deficiency.","date":"2015","source":"Journal of applied genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26608600","citation_count":8,"is_preprint":false},{"pmid":"23652424","id":"PMC_23652424","title":"Isolated central hypothyroidism in young siblings as a manifestation of PROP1 deficiency: clinical impact of whole exome sequencing.","date":"2013","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/23652424","citation_count":8,"is_preprint":false},{"pmid":"16703408","id":"PMC_16703408","title":"Waxing and waning of a pituitary mass in a young woman with combined pituitary hormone deficiency (CPHD) due to a PROP-1 mutation.","date":"2006","source":"Pituitary","url":"https://pubmed.ncbi.nlm.nih.gov/16703408","citation_count":8,"is_preprint":false},{"pmid":"26640231","id":"PMC_26640231","title":"Search for regulatory factors of the pituitary-specific transcription factor PROP1 gene.","date":"2015","source":"The Journal of reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/26640231","citation_count":7,"is_preprint":false},{"pmid":"30988269","id":"PMC_30988269","title":"Identification of a Novel PROP1 Mutation in a Patient with Combined Pituitary Hormone Deficiency and Enlarged Pituitary.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30988269","citation_count":7,"is_preprint":false},{"pmid":"19524124","id":"PMC_19524124","title":"Dimeric PROP1 binding to diverse palindromic TAAT sequences promotes its transcriptional activity.","date":"2009","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19524124","citation_count":7,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51195,"output_tokens":6082,"usd":0.122408,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14837,"output_tokens":4947,"usd":0.09893,"stage2_stop_reason":"end_turn"},"total_usd":0.221338,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"PROP1 mutations (including frameshift and missense) result in a gene product with reduced DNA-binding and transcriptional activation ability, as demonstrated by in vitro functional assays comparing mutant versus wild-type PROP1 activity; PROP1 is required for Pit1 (POU1F1) expression and is epistatic to Pit1 in pituitary development.\",\n      \"method\": \"In vitro DNA-binding and transcriptional activation assays; genetic epistasis in mouse models (Ames dwarf epistatic to Snell/Jackson dwarfism)\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro functional assays with mutagenesis replicated across multiple PROP1 mutations in the same and subsequent studies\",\n      \"pmids\": [\"9462743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The F88S missense mutation in the first helix of the PROP1 homeodomain abolishes DNA binding to a PRDQ9 Prop1 response element in gel shift assays and reduces transcriptional activation of a luciferase reporter to ~34% of wild-type, demonstrating that the hydrophobic core of helix 1 is required for DNA binding.\",\n      \"method\": \"Gel shift (EMSA) assay and luciferase reporter transcriptional activation assay in transiently transfected TSA-201 cells\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro binding and transcriptional activation assays with site-directed mutagenesis in a single study\",\n      \"pmids\": [\"10946881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Constitutive (transgenic) overexpression of PROP1 in pituitary thyrotropes and gonadotropes delays terminal differentiation of gonadotropes, causes transient hypogonadotropic hypogonadism, impairs thyrotrope function, and increases susceptibility to pituitary adenomas and Rathke's cleft cysts, demonstrating that timely silencing of PROP1 is required for normal pituitary cell differentiation.\",\n      \"method\": \"Transgenic mouse overexpression; histological and hormonal phenotyping\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean transgenic gain-of-function with defined cellular and hormonal phenotypes, replicated in follow-up studies\",\n      \"pmids\": [\"11371507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"In Prop1-deficient mice, anterior pituitary progenitors fail to differentiate and are retained in the perilumenal area of Rathke's pouch, failing to migrate to the anterior lobe; after birth these pituitaries show enhanced apoptosis and reduced proliferation because the anterior lobe is not seeded with progenitors. In contrast, Lhx4 mutants show increased cell death and temporal shift in Lhx3 activation. Double Lhx4/Prop1 mutants exhibit complete failure of all anterior pituitary cell types to differentiate, indicating overlapping but mechanistically distinct roles.\",\n      \"method\": \"Genetic epistasis (double mutants); longitudinal histological analysis; pulse-label cell migration assay; apoptosis and proliferation quantification in mouse embryos\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with double-mutant analysis and multiple orthogonal cellular readouts\",\n      \"pmids\": [\"12183375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Longitudinal studies in Prop1-deficient dwarf mice show that mutant pituitary cells are retained in the perilumenal region and fail to migrate and differentiate; after birth the mutant pituitary exhibits enhanced apoptosis and reduced proliferation due to failure to seed the anterior lobe with progenitors, providing a cellular mechanism for the pituitary hypoplasia seen in human PROP1 patients.\",\n      \"method\": \"Longitudinal volumetric analysis; BrdU pulse labeling for cell migration; apoptosis assay; proliferation cell counting in Prop1-deficient and wild-type mice\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal in vivo methods (pulse labeling, apoptosis, proliferation) in longitudinal study\",\n      \"pmids\": [\"15591534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Prop1 deficiency in mice results in near-complete absence of Notch2 expression in the developing pituitary, while other panhypopituitary mutants do not show this effect; transgenic overexpression of Prop1 is not sufficient to enhance Notch2 expression, indicating that Prop1 is necessary but not sufficient for Notch2 expression, and that Notch signaling is downstream of or parallel to Prop1 in controlling pituitary progenitor differentiation.\",\n      \"method\": \"In situ hybridization and immunostaining in Prop1 mutant and transgenic mice; analysis of Notch pathway gene expression by spatial/temporal profiling\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function and gain-of-function in vivo with specific pathway (Notch2) readout\",\n      \"pmids\": [\"14732396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The R73C mutation of PROP1 reduces transactivation capacity to 11.5% of wild-type and abolishes binding to a high-affinity DNA sequence in vitro, confirming R73 as a functionally critical residue in the homeodomain.\",\n      \"method\": \"In vitro transactivation assay and DNA binding (EMSA/gel shift) in transfected cells\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro DNA-binding and transcriptional activation assays with defined mutant\",\n      \"pmids\": [\"15531542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PROP1 is required for normal gonadotrope terminal differentiation; transgenic overexpression of PROP1 in gonadotropes and thyrotropes causes delayed LH/FSH synthesis without affecting GnRH receptor expression or transcription factors GATA2, NR5A1, TBX19, NR0B1, or TGFβ pathway members, suggesting PROP1 influences gonadotrope development by a distinct mechanism; microarray identified candidate genes Klrg1 and Prss28.\",\n      \"method\": \"Transgenic mouse overexpression; microarray gene expression analysis; immunostaining and hormonal phenotyping\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic gain-of-function with defined phenotype and exclusion of known pathway members; candidate genes not validated beyond microarray\",\n      \"pmids\": [\"16384867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In Prop1/Hes1 double mutants, cells prematurely differentiate into ACTH and alphaGSU-producing cells within Rathke's pouch; N-cadherin downregulation (required for cell movement out of Rathke's pouch) does not occur in Prop1 single mutants (where N-cadherin remains high), but does occur in double mutants, allowing cells to exit but without correct migrational cues; Slug (EMT marker) is absent in the Prop1 mutant dorsal anterior lobe, indicating Prop1 is required for EMT and cell migration during pituitary organogenesis.\",\n      \"method\": \"Genetic epistasis (Prop1/Hes1 double mutants); immunostaining for N-cadherin, Slug, and pituitary hormones; in situ hybridization\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double mutant epistasis with multiple molecular markers and defined cellular phenotypes\",\n      \"pmids\": [\"18996108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HESX1 and PROP1 form a heterodimer on an inverted TAAT motif; HESX1 binds as a monomer to TAATT but not TAAT, and in the presence of PROP1 it develops binding to an inverted TAAT motif via heterodimer formation, suggesting that as PROP1 appears in pituitary development it alters HESX1 from a repressive monomer to a heterodimeric complex with altered DNA-binding specificity.\",\n      \"method\": \"EMSA with random oligonucleotide selection; co-incubation of HESX1 and PROP1 proteins\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro EMSA demonstrating heterodimer formation, single study without functional validation of heterodimer in vivo\",\n      \"pmids\": [\"19879326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PROP1 binds preferentially as a dimer to palindromic TAAT sequences separated by 3 nucleotides (inverted TAAT motifs); dimeric binding to inverted TAAT motifs drives transcriptional activation, whereas monomeric binding to a single TAAT or inverted ATTA motif does not; SELEX identified the 11-nucleotide consensus binding motif with a required T at position 5.\",\n      \"method\": \"SELEX (Systematic Evolution of Ligands by EXponential enrichment); EMSA; transient transfection reporter assay\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — three orthogonal methods (SELEX, EMSA, reporter assay) in a single rigorous study defining the binding mechanism\",\n      \"pmids\": [\"19524124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PROP1 is expressed in SOX2-expressing stem/progenitor cells in the rat pituitary from embryonic through postnatal periods; at E13.5 PROP1 is expressed in all Rathke's pouch cells; subsequently PROP1-positive cells localize to the marginal cell layer (stem cell niche); PROP1 transiently co-localizes with PIT1 but not with hormones in the embryonic period, indicating a role in converting SOX2+ progenitors to PIT1-lineage committed cells.\",\n      \"method\": \"Immunohistochemistry on rat embryonic and postnatal pituitary sections; co-localization analysis with SOX2, PIT1, and hormone markers\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization by immunohistochemistry across developmental time points, single lab, no functional manipulation\",\n      \"pmids\": [\"19442651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GPS (GFRa2/Prop1/Stem) cells in the adult pituitary niche express PROP1 along with stem cell markers (Sox2, Sox9, Oct4) and form non-endocrine spheroids in culture that can differentiate into hormone-producing cells or neurons, indicating PROP1 marks a pituitary stem cell population with neuroectoderm potential.\",\n      \"method\": \"Immunostaining; in vitro spheroid formation and differentiation assay; BrdU label retention; telomere length analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization combined with in vitro functional differentiation assay, single lab\",\n      \"pmids\": [\"19283075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TLE1 and TLE3 (Groucho-related corepressors) interact with PROP1 and repress PROP1 transcriptional activity independently of HESX1 via direct protein-protein interaction; HESX1 represses PROP1 and this repression is augmented by TLE1 and TLE3; constitutive expression of HESX1 alone (but not TLE3 alone) suppresses terminal differentiation of thyrotropes and gonadotropes in transgenic mice.\",\n      \"method\": \"Cell culture transcriptional repression assay; transgenic mouse model with constitutive HESX1 and/or TLE3 expression; protein-protein interaction assay\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell culture functional assays with transgenic in vivo validation, reciprocal interactions tested\",\n      \"pmids\": [\"20181723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Genome-wide analysis of PROP1 DNA binding and gene expression effects in mutant mice, isolated stem cells, and engineered mouse cell lines revealed that PROP1 stimulates pituitary stem cells to undergo an epithelial-to-mesenchymal transition (EMT)-like process required for cell migration and differentiation; PROP1 binds to epithelial genes (e.g., Claudin 23) and EMT inducer genes (Zeb2, Notch2, Gli2); Zeb2 activation appears to be a key downstream step.\",\n      \"method\": \"ChIP-seq (genome-wide PROP1 DNA binding); RNA-seq in Prop1 mutant mice; functional assays in isolated pituitary stem cells and engineered mouse cell lines\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — genome-wide ChIP-seq plus transcriptomic analysis in multiple model systems defining a comprehensive PROP1-dependent gene regulatory network\",\n      \"pmids\": [\"27351100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Lineage tracing with a Prop1-Cre mouse line demonstrated that all hormone-secreting cell types of both the anterior and intermediate pituitary lobes are descended from Prop1-expressing progenitors, establishing PROP1 as marking a common multipotent progenitor for all pituitary cell lineages including gonadotropes, corticotropes, and melanotropes (not just the PIT1 lineage).\",\n      \"method\": \"Transgenic Prop1-Cre lineage tracing in mice; Cre-dependent reporter expression\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic lineage tracing experiment with defined Cre driver; human PROP1 shown to functionally substitute for mouse Prop1 in rescue experiment\",\n      \"pmids\": [\"26812162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A novel PROP1 mutation (W194X) truncating the protein in its transactivation domain reduces transactivation capacity to 34.4% of wild-type; unexpectedly, DNA-binding properties are also altered, indicating that the C-terminal end of PROP1 contributes to protein-DNA interaction.\",\n      \"method\": \"Transfection-based transactivation assay; DNA binding assay\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro functional assays (transactivation and DNA binding) with a single defined mutation, single study\",\n      \"pmids\": [\"15941866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PROP1-dependent retinoic acid (RA) signaling regulates pituitary development: Prop1-mutant mice show reduced Aldh1a2 (the enzyme converting retinaldehyde to RA) expression; conditional deletion of Aldh1a2 or dominant-negative inhibition of RA signaling during pituitary organogenesis partially phenocopies Prop1-mutant mice, including embryonic pituitary dysmorphology and reduced hormone (especially thyrotropin) expression.\",\n      \"method\": \"Conditional mouse knockout (Aldh1a2); dominant-negative transgenic mouse model; gene expression analysis\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent genetic models (conditional KO and dominant-negative) each partially phenocopy Prop1 mutation, establishing RA signaling downstream of PROP1\",\n      \"pmids\": [\"31913463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Retinoic acid (RA) signaling through RARα increases Prop1 mRNA expression in Rathke's pouch; ex vivo organ culture and in vitro reporter assays identified a cis-regulatory RARα-responsive element in the 5'-upstream region of the Prop1 gene, establishing RA/RARα as an upstream regulator of Prop1 transcription.\",\n      \"method\": \"Ex vivo Rathke's pouch organ culture with RA treatment; in vitro luciferase reporter assay with serial truncations of Prop1 5' upstream region; in situ hybridization\",\n      \"journal\": \"Journal of neuroendocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reporter assay with serial deletion constructs and ex vivo organ culture, single lab\",\n      \"pmids\": [\"29356182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Comparative genomics and transgenic functional analysis identified three conserved regulatory elements of Prop1: a promoter-proximal element, an intronic element (first intron), and a downstream element; the intronic element is sufficient to confer dorsal expansion of pituitary expression in transgenic mice, and a BAC transgene containing Prop1 completely rescues the Prop1 mutant phenotype.\",\n      \"method\": \"Comparative genomics; BAC transgene rescue; enhancer assay in cell culture; transgenic mice with intronic element driving reporter\",\n      \"journal\": \"Mammalian genome\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic rescue and cell-culture enhancer assays, multiple genomic elements tested, single lab\",\n      \"pmids\": [\"17557180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Reporter assays showed that SOX2 has cell type-dependent inhibitory and activating functions on Prop1 expression through the proximal and distal upstream regions respectively; RBP-J (Notch mediator) has small regulatory activity; 8 transcription factors (MSX2, PAX6, PIT1, PITX1, PITX2, RPF1, SOX8, SOX11) regulate Prop1 expression from its 3kb upstream region; 10 additional factors (including HES1, HEY1, FOXJ1) show synergy with SOX2.\",\n      \"method\": \"Luciferase reporter assay with 3kb upstream region and 1st intron of Prop1 in CHO and pituitary-related cell lines; systematic screening of 39 transcription factors\",\n      \"journal\": \"The Journal of reproduction and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic reporter assay with defined genomic elements and multiple transcription factors, single lab, in vitro only\",\n      \"pmids\": [\"26640231\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NESTIN-expressing rapidly dividing progenitor cells in the pituitary transition from PROP1-positive to PIT1-positive during neonatal development, indicating that the cell supply system shifts from PROP1+ stem/progenitor cells to committed PIT1+ progenitors postnatally.\",\n      \"method\": \"Immunohistochemistry for NESTIN, PROP1, and PIT1 co-expression across developmental stages; BrdU incorporation analysis\",\n      \"journal\": \"Journal of neuroendocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct multi-marker co-localization across developmental time points, consistent with lineage tracing data, single lab\",\n      \"pmids\": [\"23855824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"miR-593 and miR-511 directly target the 3'-UTR of the PROP1 gene and attenuate PROP1 protein expression, as validated by western blot and 3'-UTR reporter assay in HEK293T cells.\",\n      \"method\": \"3'-UTR luciferase reporter assay; western blot after miRNA transfection in HEK293T cells\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct 3'-UTR reporter and western blot validation of miRNA targeting, single study\",\n      \"pmids\": [\"25434367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In zebrafish, morpholino-mediated knockdown of prop1 reduces expression of pit1, prolactin (prl), and growth hormone (gh), and also unexpectedly downregulates lim3 (a gene not previously known to be Prop1-dependent); pituitary morphology and cellular organization are abnormal, but the effects are gradually reversed during late development despite persistent splice-blocking, suggesting additional compensatory pathways.\",\n      \"method\": \"Morpholino splice-blocking in zebrafish; in situ hybridization for pit1, prl, gh, tshβ, pitx3, lim3\",\n      \"journal\": \"General and comparative endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean morpholino knockdown in an orthologous model with multiple gene expression readouts, single lab\",\n      \"pmids\": [\"21362424\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PROP1 is a pituitary-specific paired-like homeodomain transcription factor that functions as an obligatory dimer binding palindromic TAAT motifs to activate transcription; it acts upstream of POU1F1 (Pit1) and is required for pituitary stem/progenitor cells to undergo an EMT-like transition enabling their migration from Rathke's pouch to the anterior lobe, where they differentiate into all anterior and intermediate lobe hormone-producing cell types — a process also dependent on downstream Notch2 and retinoic acid signaling — while its timely silencing by HESX1/TLE corepressor complexes is equally essential for terminal differentiation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PROP1 is a pituitary-specific paired-like homeodomain transcription factor that governs the migration and differentiation of multipotent anterior-pituitary progenitors, marking a common progenitor that gives rise to all hormone-secreting cell types of both anterior and intermediate lobes [#14, #15]. It functions through sequence-specific DNA binding: PROP1 binds preferentially as a dimer to palindromic (inverted) TAAT motifs separated by three nucleotides, and only this dimeric engagement drives transcriptional activation, whereas monomeric binding does not [#10]. Mutations across the homeodomain (e.g. F88S, R73C) abolish or sharply reduce DNA binding and transactivation, and even C-terminal truncation (W194X) impairs both transactivation and DNA contact, defining the homeodomain and C-terminus as essential for function [#1, #6, #16]. Genetically, PROP1 is required for and epistatic to Pit1 (POU1F1) expression [#0], and in its absence progenitors are retained in the perilumenal region of Rathke's pouch, fail to migrate to the anterior lobe, and the gland later shows excess apoptosis and reduced proliferation [#3, #4]. Mechanistically PROP1 drives an EMT-like program required for this migration—it is needed for N-cadherin downregulation and Slug expression, and genome-wide it binds epithelial and EMT-inducer genes including Zeb2, Notch2, and Gli2, with Zeb2 activation a key downstream step [#8, #14]; Notch2 expression and retinoic-acid signaling (via Aldh1a2) act downstream, while RA/RARα also feeds back to activate Prop1 transcription [#5, #17, #18]. Timely silencing of PROP1 is equally essential: HESX1 and Groucho-related corepressors TLE1/TLE3 directly bind and repress PROP1, and sustained PROP1 expression delays terminal differentiation of gonadotropes and thyrotropes [#2, #13]. Recessive PROP1 loss-of-function mutations cause combined pituitary hormone deficiency in humans, with the cellular basis being failure to seed the anterior lobe with progenitors [#0, #4].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established PROP1 as a DNA-binding transcriptional activator acting genetically upstream of Pit1, explaining a distinct dwarfism syndrome.\",\n      \"evidence\": \"In vitro DNA-binding/transactivation assays of mutant vs wild-type plus genetic epistasis in dwarf mice\",\n      \"pmids\": [\"9462743\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the DNA recognition motif\", \"Direct downstream target genes not identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mapped a structural requirement for DNA binding by showing helix 1 of the homeodomain is essential, linking patient mutations to molecular loss-of-function.\",\n      \"evidence\": \"EMSA and luciferase reporter assays with the F88S mutant in TSA-201 cells\",\n      \"pmids\": [\"10946881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single mutation; full homeodomain structure-function not mapped\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showed that PROP1 must be silenced on schedule, since constitutive overexpression delays differentiation and promotes pituitary lesions.\",\n      \"evidence\": \"Transgenic mouse gain-of-function with histological and hormonal phenotyping\",\n      \"pmids\": [\"11371507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of differentiation delay not resolved\", \"Repressors mediating silencing not yet identified\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Provided the cellular basis for hypopituitarism by showing Prop1-null progenitors are trapped in Rathke's pouch and fail to migrate, distinct from Lhx4 function.\",\n      \"evidence\": \"Double-mutant epistasis, pulse-label migration, apoptosis/proliferation assays in mouse embryos\",\n      \"pmids\": [\"12183375\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular driver of migration failure not yet defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified Notch2 as a PROP1-dependent pathway component, placing Notch signaling downstream of or parallel to PROP1 in progenitor control.\",\n      \"evidence\": \"In situ hybridization/immunostaining in Prop1 loss- and gain-of-function mice\",\n      \"pmids\": [\"14732396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PROP1 not sufficient for Notch2, so co-factors unknown\", \"Direct vs indirect regulation unresolved at this stage\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Quantified the postnatal consequences of failed progenitor seeding (apoptosis, reduced proliferation), mechanistically connecting mouse data to human pituitary hypoplasia.\",\n      \"evidence\": \"Longitudinal volumetric, BrdU migration, apoptosis and proliferation analyses\",\n      \"pmids\": [\"15591534\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional targets driving the phenotype not identified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Refined the structure-function map by showing the C-terminal transactivation domain also contributes to DNA binding.\",\n      \"evidence\": \"Transfection transactivation and DNA-binding assays of the W194X truncation\",\n      \"pmids\": [\"15941866\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single mutation, single study\", \"Structural basis of C-terminal DNA contribution unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showed PROP1 controls gonadotrope timing through a mechanism independent of known gonadotrope transcription factors, nominating new candidate targets.\",\n      \"evidence\": \"Transgenic overexpression with microarray and hormonal phenotyping\",\n      \"pmids\": [\"16384867\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Candidate genes Klrg1/Prss28 not validated beyond microarray\", \"Direct targets vs secondary effects unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined cis-regulatory architecture of Prop1 and confirmed functional sufficiency via complete BAC rescue.\",\n      \"evidence\": \"Comparative genomics, BAC transgene rescue, enhancer assays, transgenic intronic-element reporter\",\n      \"pmids\": [\"17557180\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trans-acting factors at each element not identified here\", \"Single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified PROP1 as a driver of EMT and migration, showing it is required for N-cadherin downregulation and Slug expression for exit from Rathke's pouch.\",\n      \"evidence\": \"Prop1/Hes1 double-mutant epistasis with N-cadherin, Slug and hormone marker staining\",\n      \"pmids\": [\"18996108\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct EMT target genes not yet mapped genome-wide\", \"Migrational guidance cues unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined the precise DNA recognition mechanism: dimeric binding to inverted TAAT motifs spaced by 3 nt is required for activation.\",\n      \"evidence\": \"SELEX, EMSA, and reporter assays\",\n      \"pmids\": [\"19524124\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-crystal structure of the PROP1 dimer on DNA\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed PROP1 can convert HESX1 from a repressive monomer into a heterodimer with altered DNA specificity, linking the two factors biochemically.\",\n      \"evidence\": \"EMSA with random oligonucleotide selection and HESX1/PROP1 co-incubation\",\n      \"pmids\": [\"19879326\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Heterodimer function not validated in vivo\", \"Single in vitro study\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Localized PROP1 to SOX2+ stem/progenitor cells and a stem-cell niche, supporting a role in converting progenitors to the PIT1 lineage.\",\n      \"evidence\": \"Immunohistochemistry and co-localization across rat developmental stages; in vitro spheroid differentiation of GPS cells\",\n      \"pmids\": [\"19442651\", \"19283075\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional manipulation in these descriptive studies\", \"Single-lab observations\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified the corepressor machinery silencing PROP1, showing TLE1/TLE3 and HESX1 directly repress its activity and constitutive HESX1 blocks terminal differentiation.\",\n      \"evidence\": \"Cell-culture repression and interaction assays plus transgenic HESX1/TLE3 mice\",\n      \"pmids\": [\"20181723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous timing of repressor recruitment not mapped\", \"Genomic loci of repression unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Confirmed conserved PROP1 function in an orthologous vertebrate and revealed compensatory pathways during late development.\",\n      \"evidence\": \"Morpholino splice-blocking in zebrafish with in situ hybridization for pit1, prl, gh, lim3\",\n      \"pmids\": [\"21362424\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nature of compensation unknown\", \"Knockdown not genetic null\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Documented the postnatal lineage shift from PROP1+ stem/progenitors to committed PIT1+ progenitors.\",\n      \"evidence\": \"Immunohistochemistry for NESTIN/PROP1/PIT1 and BrdU across developmental stages\",\n      \"pmids\": [\"23855824\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Descriptive co-localization without functional perturbation\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined the genome-wide PROP1 regulatory network, mechanistically establishing EMT control via direct binding to epithelial and EMT-inducer genes with Zeb2 as a key step.\",\n      \"evidence\": \"ChIP-seq and RNA-seq in mutant mice, isolated stem cells, and engineered cell lines\",\n      \"pmids\": [\"27351100\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect status of individual targets not all dissected\", \"Co-factor occupancy not fully mapped\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Lineage tracing established PROP1 as marking a common multipotent progenitor for all anterior and intermediate lobe lineages, not just the PIT1 lineage, and confirmed human PROP1 can substitute functionally.\",\n      \"evidence\": \"Prop1-Cre lineage tracing with Cre-dependent reporter and human PROP1 rescue\",\n      \"pmids\": [\"26812162\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Timing of fate restriction within the progenitor pool not resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Placed RA/RARα signaling upstream of Prop1 transcription via a defined cis-regulatory element.\",\n      \"evidence\": \"Ex vivo Rathke's pouch organ culture with RA and luciferase reporter truncation assays\",\n      \"pmids\": [\"29356182\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo requirement of the RARα element not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed RA signaling also acts downstream of PROP1, with Aldh1a2-dependent RA production required for normal pituitary morphogenesis and hormone expression.\",\n      \"evidence\": \"Conditional Aldh1a2 knockout and dominant-negative RA-signaling transgenic mice, partially phenocopying Prop1 mutants\",\n      \"pmids\": [\"31913463\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PROP1 regulation of Aldh1a2 not demonstrated\", \"Feed-forward vs feedback architecture of RA-Prop1 loop not fully resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PROP1 dimer occupancy is dynamically switched between activation (with target genes) and repression (with HESX1/TLE) at specific loci during the developmental window remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of PROP1 dimer on inverted TAAT DNA\", \"Endogenous timing/loci of HESX1-TLE recruitment vs activation not mapped\", \"Full set of direct EMT targets driving migration not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 6, 10, 14]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 6, 10, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 10, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 8, 14, 15]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 10, 14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"HESX1\", \"TLE1\", \"TLE3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}